You have requested access to member-only content.

Note from the instructor: Does COVID-19 warrant consideration of home infusion therapy?

This week's note from the instructor discusses the new home infusion therapy (HIT) benefit and how it could help in the continuum of care during the COVID-19 pandemic.

This is an excerpt from member-only content. Please log in or become a member.

Not a member? Join now!

Revenue Cycle Advisor is the key to your organization's Medicare regulatory news and education. It combines all of HCPro's Medicare regulatory and reimbursement resources into one handy and easy-to-access portal. News is not just repeated from other sources. It is analyzed by our Medicare experts so professionals can comprehend any new rule updates thoroughly.

For questions and support, please call customer service: 800-650-6787.